ALB-137391

N/A

Report date: 2022/04/08 10:18:57
NME

Base Information

Drug NameALB-137391
Drug Alias NameSMP-100CSTI-300AMR-SER-67ALB-137391(a)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsIrritable Bowel Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustraliaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesAmri
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesKelingyuan Biotechnology (Shenzhen) Co LtdChengdu Scimount Pharmatech Co Ltd
Inactive CompaniesN/A
Active IndicationsIrritable Bowel Syndrome
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A